- BioSig Technologies Inc BSGM has priced its previously announced underwritten public offering of 2.5 million shares at $4.00 per share, representing a discount of 8% from the last close price of $4.35 on Thursday.
- The gross proceeds will be approximately $10 million, or roughly $11.5 million, if the underwriter exercises its option to purchase an additional 15% of the number of shares.
- The offering will close by July 7.
- Laidlaw & Company (UK) Ltd. is acting as the sole book-running manager for the offering.
- Proceeds will be used for complete commercialization activities related to the PURE EP System, including additional support for organizational development, ongoing R&D, and general corporate purposes.
- The PURE EP System has been awarded FDA 510(k) clearance. The Company commenced commercialization in 2020.
- Price Action: BSGM shares are down 6.90% at $4.05 during the market session on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in